| 摘要 |
<p>CNRPortbl/DCC/REC/45X2394_ .DOC.3rn9/2012 -31 Abstract The present invention relates to stable compositions comprising a sphingosine 1 phosphate (S1P) receptor modulator, suitable for use as a dosage form. The S1P receptor modulators are typically sphingosine analogues, such as 2-substituted 2-amino- propane 1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising a group of formula Y.</p> |
